Gustavo Lorente

Statistics

Publications

Citations

1.1K

H-Index

Active since

2003

Affiliations

Threshold Pharmaceuticals (United States)(Current)

Rapt Therapeutics (United States)

Gustavo Lorente is an author at Threshold Pharmaceuticals (United States) specializing in life sciences, glioblastoma tumor biology, and molecular biology.

Publications per year

2003–2011

Publications

Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs

Hailong Jiao, Jacob A. Kaizerman, Timothy F. Stanton et al. · Journal of Medicinal Chemistry · 2008 · 239 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302

Fanying Meng, James Evans, Deepthi Bhupathi et al. · Molecular Cancer Therapeutics · 2011 · 206 citations

Medicine, Medicinal Chemistry, Pharmacology +17

GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion

Sumana Shashidhar, Gustavo Lorente, Usha Nagavarapu et al. · Oncogene · 2005 · 174 citations

Life Sciences, Molecular Biology, Oncology +12

Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2

Rosalyn Ram, Gustavo Lorente, Karoly Nikolich et al. · Journal of Neuro-Oncology · 2005 · 120 citations

Life Sciences, Cell Biology, Oncology +14

A role for receptor tyrosine phosphataseζ in glioma cell migration

Sabine Müller, Philip Kunkel, Katrin Lamszus et al. · Oncogene · 2003 · 118 citations

Life Sciences, Molecular Biology, Oncology +14

1–5 of 9